Clinical Trial Update: Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids [Phase 2, Phase 3]

View source ↗

Summary

A pivotal Phase 2/3 trial evaluating MR-HIFU using the Sonalleve system for uterine fibroids has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Sonalleve MR-HIFU

Snippet

Sponsor: Philips Healthcare | Conditions: Uterine Fibroids | Phase 2, Phase 3 | Status: TERMINATED